HIGHLIGHTS
- who: CYP and collaborators from the Support Force, th Hospital, China Second Military Medical University have published the research: Understanding inter-individual variability in pharmacokinetics/ pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes, in the Journal: (JOURNAL)
- what: In this study, a combined population pharmacokinetic (PPK) model of ARI and its metabolite DARI was developed. Most of the blood samples were obtained after continuous administration for at least 14 days in this study, only one blood sample was collected less than 14 days because of adverse . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.